UnknownNot Applicable

Prescription and Persistence of Antithrombotic Agents in Acute Ischemic Stroke or Transient Ischemic Attack Patients With MCA(Middle Cerebral Artery) Disease

South Korea1,000 participantsStarted 2015-12

Plain-language summary

Prescription and Persistence of Antithrombotic agents in Acute Ischemic Stroke or Transient Ischemic Attack Patients with MCA(Middle Cerebral Artery) Disease.

Who can participate

Age range19 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 19 years later, men and women Exclusion Criteria: * Subject who is judged to be ineligible by investigator

What they're measuring

Prescription status of Antithrombotic Agents

Timeframe: at 12 months after baseline(onset)

Trial details

NCT IDNCT02953405

SponsorDaewoong Pharmaceutical Co. LTD.

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2018-11

View on ClinicalTrials.gov More MCA - Middle Cerebral Artery Dissection trials